Putnam Investments’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Putnam Investments’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-95,295	Closed	-$5.64M	–	1594
2015 Q2	$5.64M	Buy	95,295 +41,615	+78%	+$2.94M	0.01%	679
2015 Q1	$5.74M	Buy	+53,680	New	+$5.12M	0.01%	737
2014 Q2	–	Sell	-13,016	Closed	-$696K	–	1540
2014 Q1	$696K	Buy	13,016 +40	+0.3%	+$1.32K	﹤0.01%	1278
2013 Q4	$327K	Hold	12,976	–	–	﹤0.01%	1412
2013 Q3	$354K	Hold	12,976	–	–	﹤0.01%	1394
2013 Q2	$468K	Buy	+12,976	New	+$486K	﹤0.01%	1333

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Putnam Investments's PTX Position: Q3 2015 in Review

Putnam Investments sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2015, closing a stake of 95,295 shares — an estimated $5.64M sold.

Putnam Investments first reported a position in PTX in Q2 2013 and held it in 6 quarters. The position peaked at $5.74M in Q1 2015. 104 funds tracked by Wall St. Rank hold PTX as of Q3 2015.

Putnam Investments reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
Putnam Investments sold 95,295 Pernix Therapeutics Holdings, Inc. shares in Q3 2015, an estimated $5.64M.
Putnam Investments first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 6 quarters.
Putnam Investments's Pernix Therapeutics Holdings, Inc. position peaked at $5.74M in Q1 2015.
104 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2015.

Based on Putnam Investments's 13F filing for Q3 2015, filed 16 Nov 2015.